- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04958759
Functional Inspiratory Muscle Training in Chronic Kidney Disease
August 11, 2023 updated by: Merve Firat, Hacettepe University
The Effects of Functional Inspiratory Muscle Training on Respiratory and Peripheral Muscle Functions in Chronic Kidney Disease
Effects of functional inspiratory muscle training by telerehabilitation on respiratory and peripheral functions, functional capacity, diaphragm thickness and mobility, posture, quality of life, cognitive function, fatigue, physical activity, endothelial function and aortic stiffness in patients with chronic kidney disease will be investigated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Hacettepe University, Faculty of Physical Therapy and Rehabilitation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with chronic kidney disease not receiving dialysis
- Access to the online program
- Volunteering to participate in the research
Exclusion Criteria:
- Having a musculoskeletal problem
- Having decompensated diabetes
- Having uncontrolled hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Functional Inspiratory Muscle Training Group
Functional inspiratory muscle training in patients with chronic kidney disease
|
The inspiratory muscle training program will be consist of 4 weeks of foundation inspiratory muscle training and 6 weeks of functional inspiratory muscle training
The inspiratory muscle training program will be consist of 10 weeks of foundation inspiratory muscle training
|
Experimental: Inspiratory Muscle Training Group
Inspiratory muscle training in patients with chronic kidney disease
|
The inspiratory muscle training program will be consist of 10 weeks of foundation inspiratory muscle training
|
Experimental: Control Group
Breathing exercises in patients with chronic kidney disease
|
The program will be consist of 10 weeks of breathing exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory muscle strength
Time Frame: 10 minutes
|
Respiratory muscle strength will be evaluated using mouth pressure device
|
10 minutes
|
Respiratory muscle endurance
Time Frame: 10 minutes
|
Respiratory muscle endurance will be evaluated using incremental load test
|
10 minutes
|
Pulmonary function
Time Frame: 5 minutes
|
Pulmonary functions will be evaluated using spirometry
|
5 minutes
|
Peripheral muscle strength
Time Frame: 5 minutes
|
Peripheral muscle strength will be evaluated using dynamometer
|
5 minutes
|
Endurance of trunk muscles
Time Frame: 10 minutes
|
Endurance of trunk muscles will be evaluated using plank, side plank, flexor endurance and pelvic bridge test
|
10 minutes
|
Lower extremity muscle endurance
Time Frame: 1 minutes
|
Lower extremity muscle endurance will be evaluated using sit-to-stand test
|
1 minutes
|
Functional capacity
Time Frame: 10 minutes
|
Functional capacity will be evaluated using six-minute walk test
|
10 minutes
|
Diaphragm thickness and mobility
Time Frame: 20 minutes
|
Diaphragm thickness and mobility will be evaluated using ultrasonography
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Balance
Time Frame: 5 minutes
|
Balance will be evaluated using timed up and go test
|
5 minutes
|
Static balance
Time Frame: 5 minutes
|
Balance will be evaluated using one-legged standing test
|
5 minutes
|
Posture
Time Frame: 5 minutes
|
Posture will be evaluated using Corbin Postural Assessment scale.
Lateral and posterior views will be assessed (0 = absent, 1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent (0-2), very good (3-4), good (5-7), fair (8-11) and poor (>12).
|
5 minutes
|
Qol
Time Frame: 10 minutes
|
Quality of life will be evaluated using Nottingham Health Profile
|
10 minutes
|
Cognitive function
Time Frame: 5 minutes
|
Cognitive function will be evaluated using Standardised Mini-Mental State Examination
|
5 minutes
|
Fatigue
Time Frame: 5 minutes
|
Fatigue will be evaluated using Multidimensional Assessment of Fatigue scale
|
5 minutes
|
Physical activity
Time Frame: 5 minutes
|
Physical activity level will be evaluated using International Physical Activity Questionnaire-Short Form
|
5 minutes
|
Endothelial function
Time Frame: 10 minutes
|
Endothelial function will be evaluated using echocardiography.
After a resting baseline Brachial artery diameter will be recorded, the cuff used in blood pressure measurement will be inflated 25-50 mmHg above the systolic blood pressure value and maintaining that pressure for 5 min.
The brachial artery diameter will be measured again after the cuff is deflated.
|
10 minutes
|
Aortic stiffness
Time Frame: 10 minutes
|
Aortic stiffness will be evaluated using transthoracic echocardiography.
Aortic diameters can be measured by M-mode tracing of the level of 3-4 cms above the aortic valve during diastole and systole
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tolga Yildirim, MD, Hacettepe University
- Study Chair: Ahmet Hakan Ates, MD, Hacettepe University
- Study Chair: Selin Ardali-Duzgun, MD, Hacettepe University
- Study Chair: Melda Saglam, PhD, Hacettepe University
- Principal Investigator: Merve Firat, MSc, Hacettepe University
- Study Director: Naciye Vardar-Yagli, PhD, Hacettepe University
- Study Chair: Deniz İnal-İnce, Professor, Hacettepe University
- Study Chair: Ebru Calik-Kutukcu, PhD, Hacettepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Actual)
September 9, 2022
Study Completion (Actual)
May 3, 2023
Study Registration Dates
First Submitted
May 12, 2021
First Submitted That Met QC Criteria
July 1, 2021
First Posted (Actual)
July 12, 2021
Study Record Updates
Last Update Posted (Actual)
August 14, 2023
Last Update Submitted That Met QC Criteria
August 11, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA-20086
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
Clinical Trials on Functional Inspiratory Muscle Training
-
Gazi UniversityNot yet recruiting
-
Biruni UniversityIstanbul Galata UniversityRecruiting
-
Dokuz Eylul UniversityUnknown
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
King Saud UniversityCompleted
-
Universidade do PortoUnknownMuscle Weakness | Dyspnea | Reactive Airways Dysfunction Syndrome (Disorder)Portugal